research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

2024 Part the Cloud Translational (PTC) Research for Alzheimer’s Disease Program (worldwide)

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The 2024 Part the Cloud Translational (PTC) Research for Alzheimer’s Disease Program from the Alzheimer’s Association seeks to advance potential therapeutics against Alzheimer’s Disease by providing support for early phase studies (Phase 1 and Phase 2). Applications will be accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing prior (Phase 1) to Proof of Concept (POC) Phase 2 or 3 efficacy studies, or with lead therapeutic agents that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study in humans to begin proving the scientific concept in humans. Applicants may be based in the USA or internationally. The grant provides up to 1 million USD, including direct and indirect costs for costs related to the proposed research for up to three years.

The letters of intent are due on November 15, 2023 and invited full applications are due on January 31, 2024. 

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time